SCHEDULE 13D: Activist Investor L.I.A. Pure Capital Seeks Control of Xylo Technologies, Proposes Full Acquisition

L.I.A. Pure Capital Ltd., holding an 8.87% stake in Xylo Technologies Ltd., has filed a Schedule 13D revealing its intent to acquire 95.24% of the company's securities, aiming for full control and a strategic overhaul.

Summary

• L.I.A. Pure Capital Ltd. and Kfir Silberman (Reporting Persons) beneficially own 2,900,000 ordinary shares of Xylo Technologies Ltd.
• This stake represents approximately 8.87% of the Issuer's 32,689,784 outstanding ordinary shares as of February 18, 2025.
• The Reporting Persons acquired the American Depositary Shares (ADSs) for an aggregate purchase price of approximately $304,500.
• Pure Capital also holds pre-funded warrants to purchase 18,190,080 ordinary shares (underlying 454,752 ADSs), acquired at a purchase price of $2.20 minus $0.001 per warrant, with an exercise price of $0.001.
• The exercise of these pre-funded warrants is subject to a beneficial ownership limitation, preventing Pure Capital from owning more than 4.99% of the Issuer's outstanding share capital immediately after exercise.
• On December 24, 2024, Pure Capital filed a request with the District Court of Tel Aviv (Economic Division) to convene a special shareholder meeting.
• The purpose of the meeting is to consider and vote on a proposed acquisition of 95.24% of Xylo Technologies' securities, which would enable the Reporting Persons to beneficially own 100% of the Issuer's securities.
• The acquisition is contingent upon approval from the Issuer's shareholders and the Israeli District Court.
• As of the filing date, no court order to convene the special meeting has been issued.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive from the perspective of the activist investor, who sees an 'attractive investment opportunity' and intends to implement changes for 'improved performance.' However, the uncertainty surrounding the acquisition's approval and the implied 'core operating deficiencies' introduce a degree of caution. The potential for a full acquisition and strategic overhaul is a significant positive for long-term value if successful, but the current state of the company is implied to be suboptimal.

Positives

• A significant investor, L.I.A. Pure Capital, views Xylo Technologies as an "attractive investment opportunity."
• The proposed acquisition, if successful, could lead to a strategic overhaul, including changes to management, optimization of assets, and a review of strategic alternatives, potentially improving company performance.

Negatives

• The proposed acquisition and strategic changes are contingent on shareholder and court approval, with no assurance of completion.
• The intent to change board and senior management, and address "core operating deficiencies," suggests current dissatisfaction with the Issuer's performance and governance.

Risks

• The proposed acquisition of 95.24% of the Issuer's securities is subject to approval by the Issuer's shareholders and the District Court of Tel Aviv, with no guarantee of success.
• There is no assurance that the Court will grant the requested relief to convene a special meeting or that the Acquisition will be completed as contemplated.
• The Reporting Persons reserve the right to modify their plans regarding the Acquisition or the Issuer at any time based on legal, regulatory, market, or other considerations.
• The exercise of pre-funded warrants is subject to a beneficial ownership limitation of 4.99%, restricting immediate full conversion.

Future Outlook

The Reporting Persons intend to monitor Xylo Technologies' business, operating results, and financial position, reserving the right to acquire or dispose of additional securities. Crucially, they are pursuing a full acquisition of the company, which, if approved by shareholders and the Israeli court, would lead to significant changes including a new board and senior management, optimization of assets and operations, and a review of strategic alternatives to improve performance. However, there is no guarantee the acquisition will be completed.

Management Comments

• "Pure Capital purchased the ADSs because it determined that such securities represent an attractive investment opportunity."
• "The Reporting Persons intend to monitor the Issuer's business, operating results and financial position and depending on market conditions and its continuing evaluation of the business and prospects of the Issuer and other factors, the Reporting Persons may dispose of or acquire additional securities of the Issuer."
• "Subject to the consummation of the Acquisition, Pure Capital intends to (1) change the Issuer's board and senior management composition, (2) optimize the Issuer's assets, operations and capital allocation strategies, (3) pursue opportunities to improve performance by addressing core operating deficiencies, and (4) initiate a review of strategic alternatives."
• "However, there can be no assurance that the Court will grant the requested relief or that the Acquisition will be completed as contemplated."
• "Pure Capital reserves the right to modify its plans with respect to the Acquisition or the Issuer at any time based on legal, regulatory, market, or other considerations."

Industry Context

This Schedule 13D filing indicates an activist investor's move to gain control of Xylo Technologies, a common strategy in the financial industry when investors identify undervalued companies or those with perceived operational inefficiencies. Such actions often signal a belief that current management is not maximizing shareholder value and that significant strategic changes are required. The attempt to take a company private or gain full control is a notable event, potentially leading to a significant restructuring or shift in business focus, which can be a trend in mature or underperforming sectors.

Management Changes

Corporate Governance

Legal Proceedings

• Pure Capital filed a request with the District Court of Tel Aviv (Economic Division) on December 24, 2024, seeking an order to convene a special meeting of Xylo Technologies' shareholders to consider and vote on a proposed acquisition of 95.24% of the Issuer's securities.

Stakeholder Impact

• Shareholders: Potential for a significant change in company control and strategy, which could lead to increased value if the acquisition and subsequent changes are successful, or uncertainty if the acquisition fails or the new strategy is ineffective. Shareholders will be asked to vote on the acquisition.
• Management/Employees: Potential for changes in senior management and board composition if the acquisition is consummated, and a review of operations which could impact employees.
• Creditors: Potential for changes in capital allocation strategies and overall financial health, which could indirectly affect creditors.

Next Steps

• Monitoring of Xylo Technologies' business, operating results, and financial position by Reporting Persons.
• Potential acquisition or disposition of additional securities by Reporting Persons.
• Discussions with other shareholders and the Issuer by Reporting Persons.
• District Court of Tel Aviv to issue an order (or not) to convene a special meeting of the Issuer's shareholders.
• Shareholder vote on the proposed acquisition of 95.24% of the Issuer's securities.
• Court approval of the acquisition.
• If acquisition consummated: change in Issuer's board and senior management composition.
• If acquisition consummated: optimization of Issuer's assets, operations, and capital allocation strategies.
• If acquisition consummated: pursuit of opportunities to improve performance by addressing core operating deficiencies.
• If acquisition consummated: initiation of a review of strategic alternatives.

Key Dates

Keywords

Xylo Technologies, L.I.A. Pure Capital, Kfir Silberman, Schedule 13D, Beneficial Ownership, Activist Investor, Corporate Acquisition, Pre-Funded Warrants, Shareholder Meeting, Corporate Governance, Strategic Review, Israel Securities Exchange Commission